What does Hivian do?
HIVIAN is a biotechnology company that specializes in developing innovative diagnostic solutions for infectious diseases, particularly focusing on HIV. The company aims to improve patient outcomes through advanced testing technologies and personalized healthcare approaches. By leveraging cutting-edge research and development, HIVIAN seeks to enhance the accuracy and efficiency of disease detection and management.
- Sectors
- Butchers Wholesalers
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.79
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 192KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.44MStrong equity provides a buffer against setbacks.
Low riskLow risk 31.8%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 1.03MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.12MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 7.1%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.44M
|
€
1.71M
|
€
1.70M
|
€
1.23M
|
|
|
€
1.12M
|
€
1.42M
|
€
1.42M
|
€
973K
|
|
|
€
95K
|
€
264K
|
€
512K
|
€
260K
|
|
|
€
2.44M
|
€
2.41M
|
€
2.20M
|
€
1.73M
|
|
|
31.78%
|
31.77%
|
27.89%
|
25.78%
|
|
|
€
5.23M
|
€
5.17M
|
€
5.69M
|
€
4.98M
|
|
|
€
111K
|
€
80K
|
€
223K
|
€
29K
|
|
|
2
|
2
|
|
2
|
Publications 24
All publications- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 10/05/2024
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Doel - Algemene Vergadering 26/06/2023
- Ontslagen - Benoemingen 10/01/2023
- Me. - Jaarrekening 30.06.2016, Ggk 25.10.2016, Ngl 30.11.2016 16687-0296-017 05/12/2016
- Ontslagen - Benoemingen 14/10/2016
Frequently asked questions
Answers to the most common questions about Hivian, based on official government data and the filed annual accounts.
What is the VAT number of Hivian?
The VAT number of Hivian is BE0875.965.923.
How many employees work at Hivian?
In 2025, Hivian employed 2.00 full-time equivalents (FTE).
When was Hivian established?
Hivian was founded in 09-09-2005.
What is the official address of Hivian?
The official address of Hivian is Bruggestraat 37 Langemark-Poelkapelle 8920.
What is the legal form of Hivian?
The juridical form of Hivian is Public limited company (NV/SA).
What is the annual revenue of Hivian?
The 2025 accounts of Hivian do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Hivian do?
HIVIAN is a biotechnology company that specializes in developing innovative diagnostic solutions for infectious diseases, particularly focusing on HIV. The company aims to improve patient outcomes through advanced testing technologies and personalized healthcare approaches. By leveraging cutting-edge research and development, HIVIAN seeks to enhance the accuracy and efficiency of disease detection and management.
Is Hivian a reliable company?
Hivian is a registered Rechtspersoon with company number 0875.965.923 and can be verified through the official CBE database.
What is the credit limit of Hivian?
The estimated credit limit of Hivian is €913,788.
Is Hivian still active?
Hivian currently has the status "Normal situation" and is active.